Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 1/20 | 0.85 |
| ▸ | PTPRC | P08575 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.49 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.49 |
| ▸ | TTR | P02766 | 1/20 | 0.48 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8033807 | 0.93 | S100A4 (0.73) | S100A4PTPRCMAPTNPC1RAB9A | |
| SCHEMBL9423385 | 0.92 | S100A4 (0.93) | S100A4PTPRCMAPTNPC1RAB9A | |
| SCHEMBL2599394 | 0.92 | S100A4 (1.00) | S100A4PTPRCMAPTNPC1RAB9A | |
| SCHEMBL6259661 | 0.88 | S100A4 (0.93) | S100A4PTPRCMAPTNPC1RAB9A | |
| SCHEMBL31268599 | 0.88 | S100A4 (0.86) | S100A4PTPRCMAPTNPC1RAB9A | |
| SCHEMBL8014885 | 0.88 | S100A4 (0.86) | S100A4PTPRCMAPTNPC1RAB9A | |
| SCHEMBL28658029 | 0.86 | S100A4 (0.66) | S100A4PTPRCMAPTNPC1RAB9A | |
| SCHEMBL16694449 | 0.86 | S100A4 (0.65) | S100A4PTPRCMAPTALDH1A1SMN1; SMN2 | |
| SCHEMBL10881228 | 0.85 | S100A4 (0.82) | S100A4PTPRCMAPTNPC1RAB9A | |
| Dimethylamine SCHEMBL7241455 | 0.83 | S100A4 (0.77) | S100A4PTPRCMAPTNPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5663030-A | A PHENYL OR NORBORNANE DERIVATIVE AS AN ADDITIVE TO REDUCE HEAT AND ENERGY REQUIRED TO FUSE THE TONER AND TO REDUCE JAMMING OF THE EQUIPMENT | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-4507462-A | CROSSLINKING AMINOKETONE ETHERS | POLYMER SCIENCE (US) | 1985-03-26 | — | — | US | claimed |
| US-20170190842-A1 | O-HYDROXY-FUNCTIONALIZED DIAMINES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE | KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (SA) | 2017-07-06 | — | — | US | disclosed |
| US-6420613-B1 | CHEMICAL REDUCTION WITH TRICHLOROSILANE | TOKUYAMA CORPORATION (JP) | 2002-07-16 | — | — | US | disclosed |
| EP-1086941-A1 | PROCESS FOR PREPARING REDUCTANTS OF UNSATURATED ORGANIC COMPOUNDS BY THE USE OF TRICHLOROSILANE AND REDUCING AGENTS | TOKUYAMA CORPORATION (JP) | 2001-03-28 | — | — | EP | disclosed |
| EP-0547162-B1 | PHENOL TERMINATED DIESTER COMPOSITION AND CURABLE COMPOSITIONS CONTAINING SAME | EXXON CHEMICAL PATENTS INC (US) | 1999-03-03 | — | — | EP | disclosed |
| US-5334671-A | Protective coating | EXXON CHEMICAL PATENTS INC. (US) | 1994-08-02 | — | — | US | disclosed |
| US-5326831-A | COATINGS | EXXON CHEMICAL PATENTS INC. (US) | 1994-07-05 | — | — | US | disclosed |
| EP-0547162-A1 | PHENOL TERMINATED DIESTER COMPOSITION AND CURABLE COMPOSITIONS CONTAINING SAME | EXXON CHEMICAL PATENTS INC. (US) | 1993-06-23 | — | — | EP | disclosed |
| US-5210155-A | Coatings and paints; hardness, high impact strength, corrosion resistance, weatherproof, solvent resistance | EXXON CHEMICAL PATENTS INC. (US) | 1993-05-11 | — | — | US | disclosed |
| WO-1992003492-A1 | PHENOL TERMINATED DIESTER COMPOSITION AND CURABLE COMPOSITIONS CONTAINING SAME | EXXON CHEMICAL PATENTS INC. (US) | 1992-03-05 | — | — | WO | disclosed |
| US-4507462-A | CROSSLINKING AMINOKETONE ETHERS | POLYMER SCIENCE (US) | 1985-03-26 | — | — | US | disclosed |
| EP-0072180-A1 | Low molecular weight aromatic polymers with biphenylene end groups | POLYMER SCIENCES CORPORATION (US) | 1983-02-16 | — | — | EP | disclosed |
| US-4269953-A | Method of crosslinking aromatic thermoplastic polymers using a biphenylene terminated compound | GENERAL DYNAMICS CORPORATION (US) | 1981-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170190842-A1 | O-HYDROXY-FUNCTIONALIZED DIAMINES, POLYIMIDES, METHODS OF MAKING EACH, AND METHODS OF USE | ALKBH3, AOC1, PAM | S100A4 2320/4885PTPRC 2330/4885MAPT 3676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.